Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 10333 | 1006 | 25.5 | 55% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HYPERKALEMIA | Author keyword | 59 | 27% | 18% | 185 |
| 2 | KAYEXALATE | Author keyword | 19 | 74% | 1% | 14 |
| 3 | HYPERKALAEMIA | Author keyword | 13 | 27% | 4% | 42 |
| 4 | SODIUM ZIRCONIUM CYCLOSILICATE | Author keyword | 8 | 100% | 0% | 5 |
| 5 | SODIUM POLYSTYRENE SULFONATE | Author keyword | 6 | 31% | 1% | 15 |
| 6 | NONOLIGURIC HYPERKALEMIA | Author keyword | 4 | 75% | 0% | 3 |
| 7 | SELECTIVE HYPOALDOSTERONISM | Author keyword | 4 | 75% | 0% | 3 |
| 8 | SODIUM POLYSTYRENE SULPHONATE | Author keyword | 4 | 75% | 0% | 3 |
| 9 | RAAS INHIBITOR | Author keyword | 3 | 100% | 0% | 3 |
| 10 | ZS 9 | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HYPERKALEMIA | 59 | 27% | 18% | 185 | Search HYPERKALEMIA | Search HYPERKALEMIA |
| 2 | KAYEXALATE | 19 | 74% | 1% | 14 | Search KAYEXALATE | Search KAYEXALATE |
| 3 | HYPERKALAEMIA | 13 | 27% | 4% | 42 | Search HYPERKALAEMIA | Search HYPERKALAEMIA |
| 4 | SODIUM ZIRCONIUM CYCLOSILICATE | 8 | 100% | 0% | 5 | Search SODIUM+ZIRCONIUM+CYCLOSILICATE | Search SODIUM+ZIRCONIUM+CYCLOSILICATE |
| 5 | SODIUM POLYSTYRENE SULFONATE | 6 | 31% | 1% | 15 | Search SODIUM+POLYSTYRENE+SULFONATE | Search SODIUM+POLYSTYRENE+SULFONATE |
| 6 | NONOLIGURIC HYPERKALEMIA | 4 | 75% | 0% | 3 | Search NONOLIGURIC+HYPERKALEMIA | Search NONOLIGURIC+HYPERKALEMIA |
| 7 | SELECTIVE HYPOALDOSTERONISM | 4 | 75% | 0% | 3 | Search SELECTIVE+HYPOALDOSTERONISM | Search SELECTIVE+HYPOALDOSTERONISM |
| 8 | SODIUM POLYSTYRENE SULPHONATE | 4 | 75% | 0% | 3 | Search SODIUM+POLYSTYRENE+SULPHONATE | Search SODIUM+POLYSTYRENE+SULPHONATE |
| 9 | RAAS INHIBITOR | 3 | 100% | 0% | 3 | Search RAAS+INHIBITOR | Search RAAS+INHIBITOR |
| 10 | ZS 9 | 3 | 100% | 0% | 3 | Search ZS+9 | Search ZS+9 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTESTINAL NECROSIS | 26 | 68% | 2% | 23 |
| 2 | DRUG INDUCED HYPERKALEMIA | 21 | 90% | 1% | 9 |
| 3 | REVERSIBLE HYPERKALEMIA | 21 | 90% | 1% | 9 |
| 4 | PLASMA POTASSIUM | 20 | 35% | 5% | 48 |
| 5 | NONOLIGURIC HYPERKALEMIA | 17 | 59% | 2% | 19 |
| 6 | HYPERKALEMIA | 17 | 15% | 10% | 103 |
| 7 | KAYEXALATE | 15 | 56% | 2% | 18 |
| 8 | COLONIC NECROSIS | 15 | 77% | 1% | 10 |
| 9 | TERMINAL RENAL FAILURE | 12 | 56% | 1% | 15 |
| 10 | HYPORENINEMIC HYPOALDOSTERONISM | 9 | 39% | 2% | 19 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system | 2004 | 195 | 44 | 39% |
| Potassium disorders - clinical spectrum and emergency management | 2006 | 46 | 47 | 77% |
| Hyperkalemia revisited | 2006 | 51 | 30 | 63% |
| Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management | 2014 | 6 | 37 | 43% |
| Management of hyperkalemia in dialysis patients | 2007 | 24 | 53 | 74% |
| Emergency interventions for hyperkalaemia - art. no. CD003235.pub2 | 2005 | 27 | 24 | 83% |
| HEPARIN-INDUCED ALDOSTERONE SUPPRESSION AND HYPERKALEMIA | 1995 | 82 | 27 | 78% |
| Hyperkalemia in dialysis patients | 2001 | 58 | 90 | 63% |
| Management of patients with acute hyperkalemia | 2010 | 16 | 25 | 80% |
| Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers | 2012 | 14 | 84 | 42% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHU HEDI CHAKER SFAX | 1 | 50% | 0.1% | 1 |
| 2 | CLEVELAND CLIN LERNER MED CWRU | 1 | 50% | 0.1% | 1 |
| 3 | GOLESTAN UNIV HOSP | 1 | 50% | 0.1% | 1 |
| 4 | NEPHROL UROL TRANSPLANT IMMUNOL | 1 | 50% | 0.1% | 1 |
| 5 | PHARMAZENTRUM 0059 | 1 | 50% | 0.1% | 1 |
| 6 | ZENT ABT ANASTHESIE PERIOPERAT MED | 1 | 50% | 0.1% | 1 |
| 7 | COMPREHENS HYPERTENS | 0 | 20% | 0.2% | 2 |
| 8 | ILSAN PAIK HOSP KOREA | 0 | 33% | 0.1% | 1 |
| 9 | MAYO CLIN VENTU | 0 | 33% | 0.1% | 1 |
| 10 | MEDSECT ENDOCRINOL DIABET METAB | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000217290 | ICI 206 970//POTASSIUM BLOOD//EUKALEMIC |
| 2 | 0.0000163118 | BODY VOLUME CONDUCTOR//PERIPHERAL EDEMA//ANASARCA |
| 3 | 0.0000081445 | POTASSIUM SECRETION//POTASSIUM ADAPTATION//ROMK |
| 4 | 0.0000065955 | STOMATIN//PSEUDOHYPERKALAEMIA//REGGIE |
| 5 | 0.0000065462 | ALDOSTERONE//EPLERENONE//SPIRONOLACTONE |
| 6 | 0.0000062915 | ALDOSTERONE EXCRETION//ELBW NEONATES//INSENSIBLE WATER LOSS |
| 7 | 0.0000053130 | PSEUDOHYPOALDOSTERONISM//TRANSIENT PSEUDOHYPOALDOSTERONISM//PSEUDOHYPOALDOSTERONISM TYPE I |
| 8 | 0.0000051763 | RENAL TUBULAR ACIDOSIS//DISTAL RENAL TUBULAR ACIDOSIS//RENAL TUBULAR ACIDOSIS RTA |
| 9 | 0.0000050838 | MULTIFOCAL ATRIAL TACHYCARDIA//CHAOTIC ATRIAL RHYTHM//CHAOTIC ATRIAL TACHYCARDIA |
| 10 | 0.0000049836 | COMPLICATIONS MYALGIA//CADMIUM INDUCED HYPERTENSION//SUCCINYLCHOLINE |